CAR-T Cell Therapy in Pediatric Acute Lymphoblastic Leukemia: From Innovations to Continuing Challenges and Future Perspectives
Masco M, Shabnam F, Ramesh K, Swathi G, Kalaivani R & Nepolean R · Journal of Pharmaceutical Research International · 2025
The most prevalent cancer in children is acute lymphoblastic leukemia (ALL), and relapsed or refractory illness still poses a significant therapeutic challenge. Because chimeric antigen receptor T-cell (CAR-T) therapy reroutes autologous T cells to identify and eliminate cancerou...
Open access
Research Article
10.9734/jpri/2025/v37i117769